ClinicalTrials.gg
Not yet recruitingNCT06795438Updated Mar 27, 2025

Effects of Green Tea on Cardiometabolic Outcomes

An interventional study of Green tea and Placebo in Cardiometabolic Syndrome, sponsored by University of Central Lancashire. Not yet recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-27.

Sponsored by University of Central Lancashire · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 55 studies in Metabolic Syndrome with a site in United Kingdom — 9 open to participants now, 10 under way, none of them phase 3. Metabolic Syndrome · United Kingdom.

Planned enrollment
26th of 48
40 · median 45
Started
2025
with 2 others
No phase
40 of 55
6 open now
Registered
50th of 55
by date
Lead sponsor
6 of 55
University of Central Lancashire

Among the 55 studies in Metabolic Syndrome with a site in United Kingdom, this one is the 26th largest by planned enrollment of the 48 interventional ones that give a count, is one of 3 that started in 2025, is one of 40 with no phase, and was the 50th registered.

Metabolic Syndrome

2,119 studies on the registry are indexed under Metabolic Syndrome; 350 are open to participants now.

Browse Metabolic Syndrome studies →

Open to participants now

9 of the 55 studies in Metabolic Syndrome with a site in United Kingdom are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 234 Metabolic Syndrome studies recruiting now, 70 (30%) set no upper age limit and 135 (58%) stop at 75 or younger; 20 take children under 18; 81 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 55 studies in Metabolic Syndrome with a site in United Kingdom, or all of them as a file.
02

Study summary

Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Green tea may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.

03

Conditions studied

  • Cardiometabolic Syndrome

Browse trials for

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy
  • Between 18 \& 65 years
  • Non-smoker
  • \< 30
  • Able to give

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Diabetes or any other metabolic/ uncontrolled hypertensive conditions
  • Food allergies to quercetin
  • Habitual consumption of quercetin
  • Not regularly taking medication or antioxidant supplements
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Green tea

    Green tea tablets 1000mg 1 x per day

    Dietary Supplement: Green tea

  • Placebo comparator
    Placebo

    Placebo control 1 x blinded placebo tablet per day

    Other: Placebo

Interventions

  • Dietary supplementTeaStudies of TeaTea pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Green tea tablets 1000mg 1 x per day

  • OtherPlacebo

    Placebo control 1 x blinded placebo tablet per day

06

What researchers measure

Primary outcomes

  1. Systolic blood pressure

    Systolic blood pressure - measured using a digital blood pressure monitor

    Time frame: Baseline

  2. Systolic blood pressure

    Systolic blood pressure - measured using a digital blood pressure monitor

    Time frame: 20 days

Secondary outcomes

  1. Diastolic blood pressure

    Diastolic blood pressure - measured using a digital blood pressure monitor

    Time frame: Baseline

  2. Diastolic blood pressure

    Diastolic blood pressure - measured using a digital blood pressure monitor

    Time frame: 20 days

  3. Percent bodyfat

    Participants percentage composition of fat - measured using bio-electrical impedance

    Time frame: Baseline

  4. Percent bodyfat

    Participants percentage composition of fat - measured using bio-electrical impedance

    Time frame: 20 days

  5. Waist to hip ratio

    Ratio of waist to hip circumference - measured using anthropocentric tape

    Time frame: Baseline

  6. Waist to hip ratio

    Ratio of waist to hip circumference - measured using anthropocentric tape

    Time frame: 20 days

  7. Blood glucose

    Capillary blood glucose - mmol/L

    Time frame: Baseline

  8. Blood glucose

    Capillary blood glucose - mmol/L

    Time frame: 20 days

  9. Blood triglycerides

    Capillary blood triglycerides - mmol/L

    Time frame: Baseline

  10. Blood triglycerides

    Capillary blood triglycerides - mmol/L

    Time frame: 20 days

  11. Triglyceride glucose index

    Calculated as the natural logarithm of (blood triglycerides x blood glucose) /2)

    Time frame: Baseline

  12. Triglyceride glucose index

    Calculated as the natural logarithm of (blood triglycerides x blood glucose) /2)

    Time frame: 20 days

  13. Blood cholesterol (Total, HDL & LDL)

    Capillary blood cholesterol - mmol/L

    Time frame: Baseline

  14. Blood cholesterol (Total, HDL & LDL)

    Capillary blood cholesterol - mmol/L

    Time frame: 20 days

  15. Coop-Wonka chart

    Psychological wellbeing - The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring

    Time frame: Baseline

  16. Coop-Wonka chart

    Psychological wellbeing - The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring

    Time frame: 20 days

  17. Beck Depression Inventory

    sychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible.

    Time frame: Baseline

  18. Beck Depression Inventory

    sychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible.

    Time frame: 20 days

  19. State Trait Anxiety Inventory

    Psychological wellbeing - the state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety.

    Time frame: Baseline

  20. State Trait Anxiety Inventory

    Psychological wellbeing - the state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety.

    Time frame: 20 days

  21. Insomnia Severity Index

    Sleep quality - The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia. The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28.

    Time frame: Baseline

  22. Insomnia Severity Index

    Sleep quality - The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia. The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28.

    Time frame: 20 days

  23. Pittsburgh Sleep Quality Index

    Sleep quality - The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components. Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality.

    Time frame: Baseline

  24. Pittsburgh Sleep Quality Index

    Sleep quality - The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components. Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality.

    Time frame: 20 days

  25. Epworth Sleepiness Scale

    Sleep quality - The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24.

    Time frame: Baseline

  26. Epworth Sleepiness Scale

    Sleep quality - The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24.

    Time frame: 20 days

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2025; primary completion for Feb 2027, 22 months later.

Of 627 non-industry interventional studies with no phase under Metabolic Syndrome, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 41. This study's planned 22 months is close to that.

Counting every sponsor, half of 677 studies reached it within 20 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2025
First posted
Jan 28, 2025
StartEst.
Apr 1, 2025
Primary completionEst.
Feb 1, 2027
CompletionEst.
Jun 1, 2027
Last update
Mar 27, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06795438
Lead sponsor
University of Central Lancashire
Responsible party
Jonathan Sinclair (Professor, University of Central Lancashire) — Principal investigator
First posted
Jan 28, 2025
Start date
Apr 1, 2025 (estimated)
Primary completion
Feb 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Mar 27, 2025

Study contacts

Jonathan Sinclair, PhD, DSc
Contact
jksinclair@uclan.ac.uk
07875651533

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Tea

Start the discussion